Potential Antioxidative and Anti-hyperuricemic Components in A. Gray Revealed by Bio-affinity Ultrafiltration with SOD and XOD

Overview

Journal Front Pharmacol

Date 2023 Nov 29

PMID 38027025

Authors

Can Liang

Yongbing Xu

Minxia Fan

Felix Wambua Muema

Guilin Chen

Mingquan Guo

Guangwan Hu

Affiliations

Soon will be listed here.

Abstract

A. Gray () is a traditional Chinese medicine with various pharmacological effects. However, its antioxidant and anti-hyperuricemia components and mechanisms of action have not been explored yet. In this study, we first assessed the antioxidant potential of with 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and ferric ion reducing antioxidant power (FRAP) assays. The results suggested that the ethyl acetate (EA) fraction of not only exhibited the strongest DPPH, ABTS radical scavenging and ferric-reducing activities, but also possessed the highest total phenolic and total flavonoid contents among the five fractions. After that, the potential superoxide dismutase (SOD) and xanthine oxidase (XOD) ligands from the EA fraction were quickly screened and identified through the bio-affinity ultrafiltration liquid chromatography-mass spectrometry (UF-LC-MS). Accordingly, norbergenin, catechin, procyanidin B2, 4-O-galloylbergenin, 11-O-galloylbergenin, and gallic acid were considered to be potential SOD ligands, while gallic acid, 11-O-galloylbergenin, catechin, bergenin, and procyanidin B2 were recognized as potential XOD ligands, respectively. Moreover, these six ligands effectively interacted with SOD in molecular docking simulation, with binding energies (BEs) ranging from -6.85 to -4.67 kcal/mol, and the inhibition constants (Ki) from 9.51 to 379.44 μM, which were better than the positive controls. Particularly, catechin exhibited a robust binding affinity towards XOD, with a BE value of -8.54 kcal/mol and Ki value of 0.55 μM, which surpassed the positive controls. In conclusion, our study revealed that possessed remarkable antioxidant and anti-hyperuricemia activities and that the UF-LC-MS method is suitable for screening potential ligands for SOD and XOD from medicinal plants.

References

Xu Y, Chen G, Guo M . Antioxidant and Anti-Inflammatory Activities of the Crude Extracts of from Kenya and Their Correlations with Flavonoids. Antioxidants (Basel). 2019; 8(8). PMC: 6721178. DOI: 10.3390/antiox8080296. View

Payne A, Mazzer A, Clarkson G, Taylor G . Antioxidant assays - consistent findings from FRAP and ORAC reveal a negative impact of organic cultivation on antioxidant potential in spinach but not watercress or rocket leaves. Food Sci Nutr. 2014; 1(6):439-44. PMC: 3951540. DOI: 10.1002/fsn3.71. View

Brillo V, Chieregato L, Leanza L, Muccioli S, Costa R . Mitochondrial Dynamics, ROS, and Cell Signaling: A Blended Overview. Life (Basel). 2021; 11(4). PMC: 8070048. DOI: 10.3390/life11040332. View

N Kolodkin A, Sharma R, Colangelo A, Ignatenko A, Martorana F, Jennen D . ROS networks: designs, aging, Parkinson's disease and precision therapies. NPJ Syst Biol Appl. 2020; 6(1):34. PMC: 7589522. DOI: 10.1038/s41540-020-00150-w. View

Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H . The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors. Oxid Med Cell Longev. 2021; 2021:1470380. PMC: 8019370. DOI: 10.1155/2021/1470380. View

Xiao Y, Hu Z, Yin Z, Zhou Y, Liu T, Zhou X . Profiling and Distribution of Metabolites of Procyanidin B2 in Mice by UPLC-DAD-ESI-IT-TOF-MS Technique. Front Pharmacol. 2017; 8:231. PMC: 5415559. DOI: 10.3389/fphar.2017.00231. View

Rumora L, Hlapcic I, Popovic-Grle S, Rako I, Rogic D, cepelak I . Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta. PLoS One. 2020; 15(6):e0234363. PMC: 7274385. DOI: 10.1371/journal.pone.0234363. View

Zhuang X, Chen G, Liu Y, Zhang Y, Guo M . New Lignanamides with Antioxidant and Anti-Inflammatory Activities Screened Out and Identified from Combining Affinity Ultrafiltration LC-MS with SOD and XOD Enzymes. Antioxidants (Basel). 2021; 10(3). PMC: 8001783. DOI: 10.3390/antiox10030370. View

Kim H, Kim J, Park S, Son H, Park G, Eo H . Anti-inflammatory activity of the extracts from Rodgersia podophylla leaves through activation of Nrf2/HO-1 pathway, and inhibition of NF-κB and MAPKs pathway in mouse macrophage cells. Inflamm Res. 2020; 69(2):233-244. DOI: 10.1007/s00011-019-01311-2. View

10.

Yang S, Lian G . ROS and diseases: role in metabolism and energy supply. Mol Cell Biochem. 2019; 467(1-2):1-12. PMC: 7089381. DOI: 10.1007/s11010-019-03667-9. View

11.

Lobo V, Patil A, Phatak A, Chandra N . Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2012; 4(8):118-26. PMC: 3249911. DOI: 10.4103/0973-7847.70902. View

12.

Yu W, Cheng J . Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective. Front Pharmacol. 2020; 11:582680. PMC: 7701250. DOI: 10.3389/fphar.2020.582680. View

13.

Chen G, Seukep A, Guo M . Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs. Mar Drugs. 2020; 18(11). PMC: 7692358. DOI: 10.3390/md18110545. View

14.

Oka S, Tsuzuki T, Hidaka M, Ohno M, Nakatsu Y, Sekiguchi M . Endogenous ROS production in early differentiation state suppresses endoderm differentiation via transient FOXC1 expression. Cell Death Discov. 2022; 8(1):150. PMC: 8976013. DOI: 10.1038/s41420-022-00961-2. View

15.

Li B, Wu J, Li X . LC-MS/MS determination and pharmacokinetic study of bergenin, the main bioactive component of after oral administration in rats. J Pharm Anal. 2018; 3(4):229-234. PMC: 5760982. DOI: 10.1016/j.jpha.2013.01.005. View

16.

Wang W, Pang J, Ha E, Zhou M, Li Z, Tian S . Development of novel NLRP3-XOD dual inhibitors for the treatment of gout. Bioorg Med Chem Lett. 2020; 30(4):126944. DOI: 10.1016/j.bmcl.2019.126944. View

17.

Mi S, Gong L, Sui Z . Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs. J Cancer. 2020; 11(17):5236-5244. PMC: 7378935. DOI: 10.7150/jca.46200. View

18.

Feng H, Chen G, Zhang Y, Guo M . Exploring Multifunctional Bioactive Components from Using Multi-Target Ultrafiltration. Front Pharmacol. 2021; 12:749189. PMC: 8573357. DOI: 10.3389/fphar.2021.749189. View

19.

Chung H, Baek B, Song S, Kim M, Huh J, Shim K . Xanthine dehydrogenase/xanthine oxidase and oxidative stress. Age (Omaha). 2013; 20(3):127-40. PMC: 3455892. DOI: 10.1007/s11357-997-0012-2. View

20.

Jiao J, Yang Y, Wu Z, Li B, Zheng Q, Wei S . Screening cyclooxygenase-2 inhibitors from Andrographis paniculata to treat inflammation based on bio-affinity ultrafiltration coupled with UPLC-Q-TOF-MS. Fitoterapia. 2019; 137:104259. DOI: 10.1016/j.fitote.2019.104259. View